Merit Medical Systems Inc (MMSI)
78.97
+1.95
(+2.53%)
USD |
NASDAQ |
May 03, 16:00
79.01
+0.04
(+0.05%)
After-Hours: 20:00
Merit Medical Systems Cash from Financing (Quarterly): -18.00M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -18.00M |
December 31, 2023 | 472.81M |
September 30, 2023 | -54.55M |
June 30, 2023 | 141.51M |
March 31, 2023 | -0.497M |
December 31, 2022 | -5.749M |
September 30, 2022 | -27.07M |
June 30, 2022 | -13.20M |
March 31, 2022 | -14.24M |
December 31, 2021 | -32.47M |
September 30, 2021 | -17.89M |
June 30, 2021 | -21.83M |
March 31, 2021 | -26.25M |
December 31, 2020 | -4.548M |
September 30, 2020 | -51.98M |
June 30, 2020 | -32.95M |
March 31, 2020 | -6.234M |
December 31, 2019 | -0.167M |
September 30, 2019 | 25.94M |
June 30, 2019 | 17.58M |
March 31, 2019 | -9.821M |
December 31, 2018 | 187.92M |
September 30, 2018 | 2.239M |
June 30, 2018 | 28.62M |
March 31, 2018 | 109.50M |
Date | Value |
---|---|
December 31, 2017 | 0.809M |
September 30, 2017 | 38.06M |
June 30, 2017 | 6.923M |
March 31, 2017 | 50.72M |
December 31, 2016 | -2.441M |
September 30, 2016 | 98.82M |
June 30, 2016 | 3.526M |
March 31, 2016 | 21.20M |
December 31, 2015 | -2.747M |
September 30, 2015 | 1.504M |
June 30, 2015 | -1.715M |
March 31, 2015 | -7.277M |
December 31, 2014 | -11.76M |
September 30, 2014 | -8.238M |
June 30, 2014 | -3.287M |
March 31, 2014 | 6.314M |
December 31, 2013 | -0.946M |
September 30, 2013 | -5.239M |
June 30, 2013 | 2.911M |
March 31, 2013 | 18.04M |
December 31, 2012 | 170.48M |
September 30, 2012 | 11.31M |
June 30, 2012 | 4.583M |
March 31, 2012 | 21.91M |
December 31, 2011 | 25.78M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-54.55M
Minimum
Sep 2023
472.81M
Maximum
Dec 2023
16.51M
Average
-13.72M
Median
Cash from Financing (Quarterly) Benchmarks
Becton Dickinson & Co | 1.705B |
Integer Holdings Corp | 163.29M |
Abbott Laboratories | -2.052B |
Boston Scientific Corp | 1.569B |
Insulet Corp | 2.20M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 36.22M |
Cash from Investing (Quarterly) | -22.05M |
Free Cash Flow | 130.63M |
Free Cash Flow Per Share (Quarterly) | 0.4042 |
Free Cash Flow to Equity (Quarterly) | 46.55M |
Free Cash Flow to Firm (Quarterly) | 24.31M |
Free Cash Flow Yield | 2.83% |